In turn, as is extensively documented, tumor cells upregulate surface PD-L1 and PD-L2 [160,161] that engage PD-1 on CTLs, thereby triggering the immunosuppressive signaling cascade described above. This evidence concerns the gene PDCD1LG2 and neoplasm.